Federal modelling suggests 'very intense' Omicron surge within weeks - Action News
Home WebMail Friday, November 22, 2024, 11:02 AM | Calgary | -10.8°C | Regions Advertise Login | Our platform is in maintenance mode. Some URLs may not be available. |
Politics

Federal modelling suggests 'very intense' Omicron surge within weeks

New modelling released today by the Public Health Agency of Canada (PHAC) suggests the highly transmissible Omicron variant will push hospital admissions to "extremely high levels" in the coming weeks as case counts reach levels never before seen in this country.

Omicron variant will push hospital admissions to 'extremely high levels,' public health agency says

Intense surge in COVID-19 hospitalizations coming soon, modelling predicts

2 years ago
Duration 1:57
Canada's public health agency is predicting an intense increase in hospitalizations caused by COVID-19 in the coming weeks.

New modelling released today by the Public Health Agency of Canada (PHAC) suggests the highly transmissible Omicron variant will push hospital admissions to "extremely high levels" in the coming weeks as case counts reach levels never before seen in this country.

While there is a lot of uncertainty about how many new infections are being reported each day due to ongoing COVID-19 testing constraints, PHAC said the current test positivity rate suggests the variant isrunningrampant and there will be "several weeks of very intense activity expected to come."

Nationally, the positivity rate is a stunning 28 per cent. That meansmore than one in four tests for the virus are coming back positive nearly five times higher than the rate at any other point in the pandemic.

Thatsky-high number maybe skewed by testing limitations, now thatsome provinces and territories are restricting testing access to groups most vulnerable to COVID-19.

Paramedics transfer a patient out of their ambulance to the emergency department at Michael Garron Hospital in Toronto on Monday, Jan. 10, 2022. Ambulances have been in short supply in some regions of Ontario. (Nathan Denette/The Canadian Press)

To maintain the health care system and the "critical functions of society," PHAC is urging Canadians to limit in-person contacts, get their booster shots and wear good quality, snug-fitting face masks to help stop transmission of a variant that is ripping through communities nationwide.

While PHAC said Omicron is likely less severe than past variants the risk of hospitalization is lower than with the Delta variant,for example the sheer number of new infections means more people will be susceptible to severe outcomes, includinghospitalization and death.

The "enormous volume of cases" the modelling suggests there could be as many as 150,000 new infections a day sometime this month is driving an increase in severe illness trends nationally, PHAC said. New hospital admissions could surge to somewhere between 2,000 and 4,000 each day, well above historichighs.

Since December, the number of people with COVID-19 being treated in hospitals has more than quadrupled to an average of over 6,779 daily, while the number in critical care has doubled to an average of over 884 daily. Meanwhile, 82 deaths are being reported each day.

While the high volume of cases is driving an increase in hospitalization rates across all age groups, thenumber of hospital and ICU admissionsis still highest among adults 80 years of age or older.

Infection rates could be stabilizing in Quebec, Ontario

People over 80 report hospitalization rates eight to 10 times higher than younger cohorts. But unlike previous pandemic waves, the Omicron wavealso has seena small but notableuptick in hospitalizations among young children.

There are early indications that the rate of new infections may be stabilizing in Ontario and Quebec. "It is quite possible that in the next few days we'll see a peak in the cases," said Dr. Theresa Tam, Canada's chief public health officer.

WATCH |Dr. Theresa Tam on current COVID modelling:

Chief public health officer says it's 'possible' Canada will see COVID cases peak in coming days

2 years ago
Duration 1:12
Theresa Tam, the chief public health officer of Canada, says the COVID-19 surge should peak in the coming days but we will know more next week.

But thenumber ofnew hospital admissions will remain high for the foreseeable futurebecause there'sa lag time between infection and severe outcomes.

"We could be like other countries seeing a sharp, sharp increase and then it coming down fairly fast. But we all just want to be cautious about pronouncing on that before we see more information," Tam said.

Omicron has wreaked havoc because it is able to evade prior immunity from past infections and vaccination. PHAC said two doses of an mRNA vaccine are not very effective against infection and symptomatic disease; it described vaccineefficacyagainst an Omicron infection as "low to very low."

However, people with two doses of a vaccine are less likely to be admitted to hospital. PHAC data suggestunvaccinated people are 19 times more likely to be hospitalized with COVID-19 thanfully vaccinated people.

"These trends clearly show that being vaccinated with two or more doses is highly protective.As booster doses continue to expand, being up-to-date with COVID-19 vaccines is expected to preserve this protection advantage," Tam said.

To prevent further strain on hospitals, PHAC is urgingvaccine holdouts to finally get a dose. More than 6.5 million eligibleCanadians are not yet fully vaccinated. Vaccine coverage among people aged 5 to 11remains stubbornly low, with just 48 per cent of kids in this age group having had at least one dose.

This image provided by Pfizer shows the company's COVID-19 Paxlovid pills. Pfizer's COVID-19 pills that were supposed to be an important weapon against the pandemic are in short supply. (Pfizer/The Associated Press)

Tam said Pfizer's promising antiviral, Paxlovid, may be a useful tool in the next phase of this pandemic fight and future federal modellingon hospitalizations and deaths may have to be updated if and when this self-administered treatment is widely available for high-risk patients.

Clinical trial results suggestPaxlovidreduced the risk of hospitalization or death by an impressive 89 per cent compared to a placebo in non-hospitalized high-risk adults with COVID-19.

Health Canada is reviewing the product now, buta post-approval delivery schedule remains uncertain.

"There's a global supply constraint andit may not be in widespread use for a while. What we're trying to do at PHAC is convene expertsto help provide some considerations as to how the initial supplies could be prioritized, much as we did with the initial batch of vaccines. That work is underway," Tam said.

CBC Newsletters

Add some good to your morning and evening.

A variety of newsletters you'll love, delivered straight to you.

...



Discover all CBC newsletters in theSubscription Centre.opens new window

This site is protected by reCAPTCHA and the Google Privacy Policy and Google Terms of Service apply.